miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 10, 2014, Pages 6534-6542

  Xie, Chao ^a   Han, Yunwei ^b   Liu, Yi ^c   Han, Lei ^d   Liu, Jie ^e  

^a SHANDONG UNIVERSITY   (China)

^b THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^c Shandong Center for Disease Control and Prevention   (China)

^d JINING MEDICAL UNIVERSITY   (China)

^e SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Cell proliferation; IHC; Lung cancer; miRNA 124; NSCLC; Sox8; Survival analysis

Indexed keywords

3' UNTRANSLATED REGION; MICRORNA; MIRN124 MICRORNA, HUMAN; SOX8 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

3' UNTRANSLATED REGION; ADULT; CANCER STAGING; CELL PROLIFERATION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADULT; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; SIGNAL TRANSDUCTION; SOXE TRANSCRIPTION FACTORS; TIME FACTORS; TRANSFECTION;

EID: 84912065800     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Siegel R, Ma J, Zou Z and Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Herlofsen SR, Hoiby T, Cacchiarelli D, Zhang X, Mikkelsen TS and Brinchmann JE. Brief report: importance of SOX8 for in vitro chondrogenic differentiation of human mesenchymal stromal cells. Stem Cells 2014; 32: 1629-35.
3. Zhang S, Zhu C, Zhu L, Liu H, Liu S, Zhao N, Wu J, Huang X, Zhang Y, Jin J, Ji T and Ding X. Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma. Med Oncol 2014; 31: 918.
4. Qin GQ, He HC, Han ZD, Liang YX, Yang SB, Huang YQ, Zhou L, Fu H, Li JX, Jiang FN and Zhong WD. Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer. Onco Targets Ther 2014; 7: 137-146.
5. Sarkar A and Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell 2013; 12: 15-30.
6. Schepers GE, Teasdale RD and Koopman P. Twenty pairs of sox: extent, homology and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell 2002; 3: 167-170.
7. Castillo SD and Sanchez-Cespedes M. The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin Ther Targets 2012; 16: 903-919.
8. Takada S, DiNapoli L, Capel B and Koopman P. Sox8 is expressed at similar levels in gonads of both sexes during the sex determining period in turtles. Dev Dyn 2004; 231: 387-395.
9. O'Bryan MK, Takada S, Kennedy CL, Scott G, Harada S, Ray MK, Dai Q, Wilhelm D, de Kretser DM, Eddy EM, Koopman P and Mishina Y. Sox8 is a critical regulator of adult Sertoli cell function and male fertility. Dev Biol 2008; 316: 359-370.
10. Schlierf B, Friedrich RP, Roerig P, Felsberg J, Reifenberger G and Wegner M. Expression of SoxE and SoxD genes in human gliomas. Neuropathol Appl Neurobiol 2007; 33: 621-630.
11. Cheng YC, Lee CJ, Badge RM, Orme AT and Scotting PJ. Sox8 gene expression identifies immature glial cells in developing cerebellum and cerebellar tumors. Brain Res Mol Brain Res 2001; 92: 193-200.
12. Schepers GE, Bullejos M, Hosking BM and Koopman P. Cloning and characterization of the Sry-related transcription factor gene Sox8. Nucleic Acids Res 2000; 28: 1473-1480.
13. Jiang SS, Fang WT, Hou YH, Huang SF, Yen BL, Chang JL, Li SM, Liu HP, Liu YL, Huang CT, Li YW, Jang TH, Chan SH, Yang SJ, Hsiung CA, Wu CW, Wang LH and Chang IS. Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res 2010; 16: 4363-4373.
14. Waldman SA and Terzic A. Applications of microRNA in cancer: Exploring the advantages of miRNA. Clin Transl Sci 2009; 2: 248-249.
15. Bader AG, Brown D, Stoudemire J and Lammers P. Developing therapeutic microRNAs for cancer. Gene Ther 2011; 18: 1121-1126.
16. Kang J, Lee SY, Lee SY, Kim YJ, Park JY, Kwon SJ, Na MJ, Lee EJ, Jeon HS and Son JW. microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3. Exp Ther Med 2012; 3: 149-153.
17. Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, Cao DX, Chen GQ, He JR and Zhao Q. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 2013; 34: 713-722.
18. Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, Sze J, Leung GK, Lu G, Chan DT, Bian XW, Kung HF, Poon WS and Lin MC. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem 2012; 287: 9962-9971.
19. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I and Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766-776.
20. Yu C, Liu Y, Tan H, Li G, Su Z, Ren S, Zhu G, Tian Y, Qiu Y and Zhang X. Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition. Cancer Lett 2014; 343: 258-267.
21. Lewis BP, Burge CB and Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
22. Lu Y, Yue X, Cui Y, Zhang J and Wang K. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. Biochem Biophys Res Commun 2013; 441: 873-879.
23. Mishima T, Mizuguchi Y, Kawahigashi Y, Takizawa T and Takizawa T. RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS. Brain Res 2007; 1131: 37-43.
24. Hunt S, Jones AV, Hinsley EE, Whawell SA and Lambert DW. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett 2011; 585: 187-192.
25. Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, Sze J, Leung GK, Lu G, Chan DT, Bian XW, Kung HF, Poon WS and Lin MC. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem 2012; 287: 9962-9971.
26. Makeyev EV, Zhang J, Carrasco MA and Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 2007; 27: 435-448.
27. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, Kung HF and Xie D. The putative tumor suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 2012; 61: 278-289.
28. Wang MJ, Li Y, Wang R, Wang C, Yu YY, Yang L, Zhang Y, Zhou B, Zhou ZG and Sun XF. Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer. Int J Colorectal Dis 2013; 28: 183-189.
29. Zhou CH, Ye LP, Ye SX, Li Y, Zhang XY, Xu XY and Gong LY. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival. J Exp Clin Cancer Res 2012; 31: 18.
30. Wang G, Lunardi A, Zhang J, Chen Z, Ala U, Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, Carver B, Liu XS, Taulli R, Kuo WP, Nardella C, Signoretti S, Cordon-Cardo C, Gerald WL and Pandolfi PP. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nat Genet 2013; 45: 739-746.
31. Sun L, Mathews LA, Cabarcas SM, Zhang X, Yang A, Zhang Y, Young MR, Klarmann KD, Keller JR and Farrar WL. Epigenetic regulation of SOX9 by the NF-kappaB signaling pathway in pancreatic cancer stem cells. Stem Cells 2013; 31: 1454-1466.
32. Wu K, Ning Z, Zeng J, Fan J, Zhou J, Zhang T, Zhang L, Chen Y, Gao Y, Wang B, Guo P, Li L, Wang X and He D. Silibinin inhibits beta-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Cell Signal 2013; 25: 2625-2633.
33. Boeri M, Pastorino U and Sozzi G. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Cancer J 2012; 18: 268-274.
34. Cheng LC, Pastrana E, Tavazoie M and Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009; 12: 399-408.
35. Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie Y, Li S, Tang G, Tang H and He X. microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. Mol Cell Biochem 2014; 392: 153-9.
36. Liu K, Zhao H, Yao H, Lei S, Lei Z, Li T and Qi H. MicroRNA-124 regulates the proliferation of colorectal cancer cells by targeting iASPP. Bio-med Res Int 2013; 2013: 867537.
37. Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, Xu X, Wu J, Zhu Y, Zheng X, Luo J and Xie L. MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1. J Transl Med 2013; 11: 276.
38. Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji Y, Wang J, Zhao H and Han ZC. MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. Cell Physiol Biochem 2013; 31: 823-832.